glutathione and triple negative breast cancer GSTP1 Is a Driver of Triple-Negative Cell Metabolism Pathogenicity GPX4 Inhibitor Resistance and Metastatic
GPX4 Inhibitor Resistance and Metastatic Features in TripleNegative Breast Cancer Sabatier 2026 Advanced Science Wiley Online Library Activation of the eIF2 ATF4 axis drives triple negative breast cancer radioresistance by promoting glutathione biosynthesis ScienceDirect A review of biological targets and therapeutic approaches in the management of triple negative breast cancer ScienceDirect Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis augment to surmount triple negative breast cancer ScienceDirect
Pay in 4 interest-free payments of $6.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 19 - Sep 24



